| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |